AzTrials
AzTrials

Epidural; AnesthesiaNCT04352283

Does Ultrasound Increase the First-pass Success of Epidural Space Identification in Obese Parturients

A study testing Preprocedural ultrasound exam of lumbar spine in people with Epidural; Anesthesia, run by University Hospital, Caen at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Obesity is associated with difficulties in epidural space catheterization. The investigators want to prove that a pre-procedural ultrasound exam of lumbar spine increase the first-pass success rate of the epidural space identification among obese parturients. Read more about this study

Who is it for?
Any age, women only
Conditions the study is for
Epidural; Anesthesia
What is being tested?
Preprocedural ultrasound exam of lumbar spine
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
56 participants
Where
1 siteFrance
Study dates
6 Apr 2019to 28 Feb 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Full-term parturients (≥ 37 weeks of amenorrhea)
  • With pre-pregnancy BMI ≥ 30 kg/m2
  • Admit for a vaginal delivery
  • Receiving labour epidural analgesia

Who cannot join

  • Usual contraindications for neuraxial anesthesia (thrombocytopenia, coagulopathy, uncorrected hypovolemia, infected puncture site, intracranial hypertension)
  • Emergency maternal and foetal cases
  • Twin pregnancy
  • Marked spinal deformity ou previous spinal surgery
  • Refusal to participate

Trial locations and contacts

1 site in 1 country.

France1 site
  • University Hospital of Cote de Nacre

    Caen, 14000

Other trials in France

About this study

Official title: Does Preprocedural Ultrasound Exam of Lumbar Spine Increase the First-pass Success Rate of Epidural Space Identification Among Obese Parturients: A Randomized Controlled Open Trial

Obesity is associated with difficulties in epidural space catheterization. The investigators want to prove that a pre-procedural ultrasound exam of lumbar spine increase the first-pass success rate of the epidural space identification among obese parturients.

Read the detailed description

This study was a randomized controlled open trial with two parallel groups.

Study was conducted in only one center : the maternity of University Hospital of Caen (Normandy, France)

Written informed consent was obtained from eligible subjects after the pre-anesthetic interview in the 8th month of pregnancy.

Operators were medical interns or residents in anesthesiology. Before inclusion, they all spent an individual interview in the aim to practice ultrasound exam of lumbar spine.

Eligible subjects were full-term parturients with pre-pregnancy BMI ≥ 30 kg/m2 undergoing vaginal delivery and receiving epidural labor analgesia. Exclusion criteria were usual contraindications for neuraxial anesthesia, marked spinal deformity, previous spinal surgery and emergency context.

The study subjects were randomly assigned to palpation or ultrasound using sealed opaque envelopes containing group allocation.

Standard monitors were applied and patients were positioned sitting during landmark identification and throughout the anesthetic procedure.

In control group, needle-puncture site was determinate by the conventional technique of cutaneous palpation. Conventional palpation of the anatomical landmarks was performed and the intercristal line (Tuffier) was assumed to cross the spine at L4 spinous process or L3-L4 interspace. The skin was marked with horizontal and vertical lines at the L3-L4 and L2-L3 interspaces.

In experimental group, ultrasound exam of lumbar spine allowed to determinate the puncture site. A systematic approach described by Balki [1] was performed, using a portative ultrasound device with a 5-2 MHz curved array probe (Samsung HM70A, Samsung medical France, St-Ouen, France).

The epidural space was located using a midline approach with loss of resistance (saline solution) using and 18-gauge Tuohy needle. After successful identification of the epidural space, a 20-gauge multiorifice epidural catheter was inserted through the Tuohy needle up to 5 cm into the epidural space.The epidural analgesia protocol was PCEA (Patient Controled Epidural Analgesia) using subsequent admixture : lévo-bupivacaïne (0,625 mg/ml), sufentanil (0,02 µ/ml), clonidine (37 µg/ml).

The primary outcome was the rate of successful epidural space identification at the first needle pass (one skin puncture without redirection).

Secondary outcomes are described further.

Early procedural complications and delivery modalities (C-section, forceps) were notified.

An interview was planned 48 hours after the procedure for each parturient in the aim to assess the maternal satisfaction and detect late procedure complications.

Assuming α = 0.05 and β = 0.2 (80% power) risks and using the χ2 test, 28 patients were required in each group.

Being tested
Preprocedural ultrasound exam of lumbar spine
Keywords
ultrasound, obesity, epidural analgesia, vaginal delivery
Medical subject headings
Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Preprocedural ultrasound exam of lumbar spineDevice

    Preprocedural ultrasound exam of lumbar spine used to determinate needle puncture site

Study groups in NCT04352283
Study groupRoleWhat they receive
palpationNo interventionUsual method to determinate needle puncture site
UltrasoundExperimentalUltrasound preprocedural exam used to determinate needle puncture site
Receives: Device: Preprocedural ultrasound exam of lumbar spine

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Success of the epidural space identification at the first needle pass

    Succes rate of the epidural space identification at the first needle pass (first skin puncture and without needle redirection) for each group

    Measured: Baseline up to 1 hour

Secondary outcomes (11)
  1. Success of the epidural space identification at the first skin puncture

    Success rate of the epidural space identification at the first needle pass (first skin puncture with at least one redirection) for each group

    Measured: Baseline up to 1 hour

  2. Number of skin punctures

    Number of skin punctures per parturient

    Measured: Baseline up to 1 hour

  3. Number of needle redirections

    Number of needle redirections per parturient

    Measured: Baseline up to 1 hour

  4. Number of intervertebral space punctured

    Number of intervertebral space punctured per parturient

    Measured: Baseline up to 1 hour

  5. Duration of the epidural procedure

    Duration of the epidural procedure in seconds, measured from the first skin puncture to the test dose

    Measured: Baseline up to 1 hour

  6. Early Failed of the epidural analgesia

    Early Failed epidural analgesia, defined by the epidural analgesia remplacement within 30 minutes

    Measured: 30 minutes after the end of the procedure

  7. Verbal Rating Scale

    Verbal Rating Scale (VRS) of pain measured after the epidural procedure : from 0 (no itch) to 10 (worst imaginable itch)

    Measured: 30 minutes and 120 minutes after the epidural procedure

  8. Accidental Dural puncture

    Occurence of accidental dural puncture during the epidural procedure

    Measured: Baseline up to 1 hour

  9. Post dural puncture headache

    Occurence of Post dural puncture headache after the epidural procedure

    Measured: 48 hours after the epidural procedure

  10. Quality of epidural analgesia

    Maternal perception of epidural analgesia quality during the labour : from 1 (very bad) to 5 (excellent)

    Measured: 48 hours after the epidural procedure

  11. Maternal perception of the duration of the epidural procedure

    Maternal perception of epidural procedure duration : from 1(very short) to 5 (very long)

    Measured: 48 hours after the epidural procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Apr 2020
  2. Study start6 Apr 2019
  3. Primary completion8 Apr 2019
  4. Study completion28 Feb 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
randomized controlled open trial
Masking
None (open label)
Enrolment
56 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04352283
Sponsor's protocol ID
2018-A02752-53
Status last verified
Mar 2019
First submitted
29 Mar 2020
Last updated
5 May 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Balki M. Locating the epidural space in obstetric patients-ultrasound a useful tool: continuing professional development. Can J Anaesth. 2010 Dec;57(12):1111-26. doi: 10.1007/s12630-010-9397-y. Epub 2010 Nov 11. English, French.

    PubMed 21063818

Questions about this trial

What is this clinical trial studying?

A study testing Preprocedural ultrasound exam of lumbar spine in people with Epidural; Anesthesia, run by University Hospital, Caen at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 May 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Success of the epidural space identification at the first needle pass (time frame: Baseline up to 1 hour). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04352283, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 May 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in